CN113181209A - Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof - Google Patents
Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof Download PDFInfo
- Publication number
- CN113181209A CN113181209A CN202110470601.9A CN202110470601A CN113181209A CN 113181209 A CN113181209 A CN 113181209A CN 202110470601 A CN202110470601 A CN 202110470601A CN 113181209 A CN113181209 A CN 113181209A
- Authority
- CN
- China
- Prior art keywords
- hydrogen chloride
- equal
- less
- bioelectricity
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims abstract description 118
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 title claims abstract description 115
- 229910000041 hydrogen chloride Inorganic materials 0.000 title claims abstract description 115
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 10
- 230000004089 microcirculation Effects 0.000 claims abstract description 56
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 46
- 239000000126 substance Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000011780 sodium chloride Substances 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 22
- 239000008213 purified water Substances 0.000 claims abstract description 17
- 230000003204 osmotic effect Effects 0.000 claims abstract description 12
- 230000036541 health Effects 0.000 claims abstract description 11
- 201000004384 Alopecia Diseases 0.000 claims abstract description 10
- 206010006895 Cachexia Diseases 0.000 claims abstract description 9
- 230000032683 aging Effects 0.000 claims abstract description 9
- 231100000360 alopecia Toxicity 0.000 claims abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 9
- 208000026500 emaciation Diseases 0.000 claims abstract description 9
- 230000002572 peristaltic effect Effects 0.000 claims abstract description 9
- 239000000654 additive Substances 0.000 claims abstract description 8
- 230000000996 additive effect Effects 0.000 claims abstract description 8
- 208000035475 disorder Diseases 0.000 claims abstract description 8
- 206010033675 panniculitis Diseases 0.000 claims abstract description 7
- 210000004304 subcutaneous tissue Anatomy 0.000 claims abstract description 7
- 210000004204 blood vessel Anatomy 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 25
- 230000003750 conditioning effect Effects 0.000 claims description 24
- 230000001737 promoting effect Effects 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 15
- 239000012535 impurity Substances 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 230000010412 perfusion Effects 0.000 claims description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 210000004209 hair Anatomy 0.000 claims description 5
- 230000014639 sexual reproduction Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 210000005036 nerve Anatomy 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 241001268993 Heterochrosis Species 0.000 claims description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 241000607142 Salmonella Species 0.000 claims description 3
- 241000607768 Shigella Species 0.000 claims description 3
- 241000191967 Staphylococcus aureus Species 0.000 claims description 3
- 229910052785 arsenic Inorganic materials 0.000 claims description 3
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 3
- 244000052616 bacterial pathogen Species 0.000 claims description 3
- 229910052793 cadmium Inorganic materials 0.000 claims description 3
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229960001701 chloroform Drugs 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 210000002249 digestive system Anatomy 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052753 mercury Inorganic materials 0.000 claims description 3
- 230000036284 oxygen consumption Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000003796 beauty Effects 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 abstract description 9
- 208000008589 Obesity Diseases 0.000 abstract description 8
- 235000020824 obesity Nutrition 0.000 abstract description 8
- 230000009471 action Effects 0.000 abstract description 7
- 230000033228 biological regulation Effects 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 7
- 230000001965 increasing effect Effects 0.000 abstract description 6
- 230000001766 physiological effect Effects 0.000 abstract description 4
- 230000001850 reproductive effect Effects 0.000 abstract description 4
- 230000036299 sexual function Effects 0.000 abstract description 4
- 238000000746 purification Methods 0.000 abstract description 2
- 230000006870 function Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 9
- 150000007524 organic acids Chemical class 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 150000007522 mineralic acids Chemical group 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 230000035479 physiological effects, processes and functions Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000002567 autonomic effect Effects 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 201000001880 Sexual dysfunction Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 231100000872 sexual dysfunction Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 108010047320 Pepsinogen A Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 210000001268 chyle Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof, wherein the moderate hydrogen chloride component comprises purified water, food-grade additive hydrogen chloride and food sodium chloride, the content of the sodium chloride in the purified water is 0-3000 mg/100-1000 ml, and the food-grade additive hydrogen chloride (purification) is used for regulating the pH value of the moderate hydrogen chloride component. The invention enhances the tidal force effect of the natural self-discipline peristaltic osmotic pressure of human microcirculation by increasing the action of the hydrogen chloride substance on the bioelectricity conduction transmitter of human channels and collaterals through the moderate hydrogen chloride component, achieves the deep regulation of human subcutaneous tissue microcirculation and the deep regulation of human organ microcirculation, maintains and improves the smoothness and the transportability formed by human microcirculation power, ensures the metabolism of human body, naturally and effectively controls and resolves the obesity, the emaciation, the alopecia, the aging of the face and the sexual function reproductive disorder of human body, and keeps the young physical state and the physiological activity of human body health.
Description
Technical Field
The invention relates to the new application field of hydrogen chloride substances, in particular to a moderate hydrogen chloride component for conditioning bioelectricity of human channels and collaterals and application thereof.
Background
The medical science verifies the objective existence of the meridians in the living human body, and the bioelectricity of the human body is the guarantee for promoting the transmission of transmitter radioactive source power by the meridians. The bioelectricity perceived by human is the resting electrical effect of human body, which changes with the degree of health and age. The bioelectricity which is not sensed by people is that human body channels and collaterals conduct transmitter to act on microcirculation to form self-discipline peristaltic osmosis osmotic pressure tidal force perfusion waves which continuously correspond to the heart power to promote the whole circulation of human blood vessels.
The meridian theory of traditional Chinese medicine has a long history, and the research on the actual effect of modern meridians is more fruitful, and the achievements push the physiological medicine theory and practice level of traditional Chinese medicine to a brand new level. For example, the relationship between the major circulation and the minor circulation of the meridians and collaterals of the human body (Lee's theory), the tidal power of the microcirculation of the human body (Hei's theory), the bioelectricity function and the microcirculation metabolism of the meridians and collaterals of the human body, and the like form the scientific principle of meridian conduction, bioelectricity, microcirculation tidal wave, microcirculation metabolism, smooth microcirculation and transmission. Through research and practice of a complete result chain, the power effect of human body meridian bioelectricity on human body microcirculation transmission transmitters is discovered. Therefore, through the intervention of a certain foreign substance, the human body meridian bioelectricity kinetic energy effect is better promoted, the human body microcirculation smoothness and the human body microcirculation transportability are improved and strengthened, and the human body microcirculation bioelectricity regulation and transportation device has natural and unique effects on the regulation of obesity, emaciation, alopecia, aging of the face and sexual function reproductive disorders and the like of the human body.
Researches find that the natural nature of bioelectricity of human meridians depends on the health degree of human bodies, the bioelectricity is high in health degree, the bioelectricity is weak when the health degree is low, for example, obese people, weak people, alopecia people, aging people, sexual dysfunction and the like, the microcirculation in local or multiple parts of the bioelectricity is obstructed, and is wrapped or depressed by metabolic waste, the elasticity is weakened, when the more the retention of the metabolic waste is, the more the power of the bioelectricity of the meridians is reduced, the microcirculation in local or multiple parts is unsmooth, the peristaltic capacity of the blood vessels is insufficient, and the conditions of negative sedimentation, blockage and the like of the blood vessels are gradually formed.
The bioelectricity function of human body channels and collaterals is enhanced, the lack of power of human body microcirculation can be effectively improved, the slow pulsation is eliminated, the elasticity and the toughness of blood vessels are recovered, the fat metabolites deposited on the outer wall of the blood vessels do not survive, the peristalsis of blood vessel intima is stimulated at the same time, the smoothness of the microcirculation blood vessels is promoted, the conveying of the microcirculation blood vessels is triggered, the nutrition is achieved, the absorption, consumption and discharge of organism and organ cells are met, and the physiological activity of the human body is maintained and improved.
It is clear from textbooks on physiology of medicine that gastric acid is Hydrogen Chloride (HCL), is colorless and transparent gastric fluid, has a pH of 0.9-1.5, and secretes 1.5-2.5L of gastric fluid per day for normal adults. Because of the limited nature of natural secretion, the human body must maintain and promote the kinetic energy of bioelectricity in the channels and collaterals by adding a proper amount of hydrogen chloride components as much as the sodium chloride. Both hydrogen chloride and sodium chloride are inorganic substances and are energy substances needed by human bodies. The hydrogen chloride is inorganic acid, which has the same property with the carbonic acid binary weak acid. Inorganic acids, nutrient organic substances and organic acids of chyle are present in the human body. Organic and inorganic substances are two different substances, and therefore organic and inorganic acids are also distinct properties and actions, as specified below:
1. organic acids are acids (acetic acid, citric acid, etc.) produced by plants or animals, and acids produced by fermentation and acids produced by self-production are nutrients absorbed by human body, and they combine with organic substances to produce biological reaction, catalysis, halogenation and fermentation to decompose the organic substances. The body acidification is caused by organic acid formed by the storage and brewing of organic matters (the pH value of the human body is lower than 7.3 for a long time, acidic physique can be formed, the body is in a sub-health state which is manifested by discomfort, easy fatigue, lassitude, insufficient physical strength, resistance reduction and the like), and the organic acid directly contacts with the human body and has a corrosive effect to generate inflammatory consequences.
2. The carbonic acid and the hydrogen chloride of the inorganic acid are substances with natural components, do not react with organic matters and organic acids in a common way, and have the functions of protecting and preserving organisms and organic matters. The human body contains a large amount of natural carbonic acid, but the hydrogen chloride is little, and the stomach secretion of normal adults is about 1.5-2.5L in day and night, and the secretion of people who are sub-healthy and weak and sick is less.
Two organic and inorganic substances with different properties coexist in a human body, and have natural and objective properties and functions of human physiology. Organic matters or organic acids are nutrients needed by human bodies, and inorganic matters or inorganic acids (sodium chloride and hydrogen chloride) have nutrition factors and also maintain the organic matters and the organisms and are not developed.
In medicine, the treatment of gastropathy (such as atrophic gastritis) by taking hydrogen chloride is to make up for the deficiency of gastric acid and hydrogen chloride. In fact, 1.5-2.5L of hydrogen chloride is not enough to be used for generating gastric acid by human body per se, and cannot meet the increasing demand of human body. The physiology of people is vigorous in young age, and the hydrogen chloride secreted by the stomach only matches the needs of the human body, thereby meeting the dynamic function of the bioelectricity of the human body channels and collaterals. When growth is mature and stable, the demand needs to be constant. However, with the increase of age and the difference and change of health degree, the hydrogen chloride amount secreted by the stomach is gradually reduced, the matching amount required by the human body normally is reduced, the bioelectricity power of the human body channels and collaterals is gradually reduced, the self-peristalsis osmotic pressure capability of the human body microcirculation blood vessels is gradually reduced, the elasticity of the walls of the blood vessels is weakened, the toughness is weakened, and the metabolism is retarded. This causes obesity, emaciation, alopecia, aging of the face and sexual disorder.
Therefore, the proper addition of proper hydrogen chloride components to human body can meet the requirement of human body physiological meridian biological electric conduction transmitter, enhance the kinetic energy of human body microcirculation, protect the elasticity and toughness of blood capillary, promote the smoothness of blood capillary circulation and the transportation of nutrition, promote the absorption, consumption and discharge of body cells, thereby strengthening the function of human body physiological microcirculation self-discipline peristaltic osmotic pressure operation, reducing the accumulation and retardation of various metabolites and the bad symptoms of human body absorption and consumption, leading the human body to differentiate physiological disorder and keeping healthy state.
The Hydrogen Chloride (HCL) is inorganic strong acid, and has high concentration and burning corrosivity. But the moderate hydrogen chloride component (pH value of 0.1-6.9) has no burning corrosiveness and has no damage and harm to organisms and organic matters. The moderate hydrogen chloride component has lubrication and protection effects on human body, skin membrane, blood vessel membrane and gastrointestinal mucosa at pH value of 0.9-6.9. The moderate hydrogen chloride component still belongs to strong acid and has strong conductivity. The action on human body channels and collaterals bioelectricity is better than other substances, such as sodium chloride, calcium chloride, bicarbonate and the like.
The quantity of HCL (hydrogen chloride) naturally secreted by gastric juice in a human body is limited, and only 1.5-2.5L or even less of HCL per day can not match the requirements of the human body in different periods of different degrees. However, people have insufficient knowledge of the application of hydrogen chloride and cannot eat and supplement the hydrogen chloride like sodium chloride every day. Therefore, the lack of bioelectricity in the meridians of the human body can cause unstable power. In addition, after the human body grows in adolescence, the secretion of the gastric juice Hydrogen Chloride (HCL) begins to decline gradually, so that the bioelectricity kinetic energy of the human body meridians and collaterals is gradually weakened along with the growth of the age. The reduction of the biological electric kinetic energy of the meridians and collaterals gradually causes the reduction of tidal force of perfusion of microcirculation and microcirculation blood vessels, the natural reduction of elasticity, toughness and permeability of vessel walls, the gradual retardation of blood vessel flow, the surplus and deposition of various nutrients and the unsmooth metabolism. The following phenomena occur day after day:
firstly, the inertia accumulation is formed for a long time to limit the elastic action of the tube wall, so that the tube wall metabolite fat of the subcutaneous tissue micro blood vessel and the organ micro blood vessel is increased, and the obesity change and the body state deformation of different parts of a human body are highlighted;
secondly, the blood vessel autonomic peristalsis osmotic pressure movement is weakened, the permeability is weakened therewith, the nutrient transported by the blood vessel can not be supplied to the body cells smoothly, the absorption and the consumption of the nutrition of the body cells are influenced, the malnutrition of the human body is caused, and the human body is thin and weak and is not healthy.
Thirdly, the end of the subcutaneous blood vessel is lack of the power of the autonomic peristalsis, the osmotic pressure and the osmolysis, the secretion of the metabolite is blocked, the metabolite is deposited and blocks the channel, and the transportation of the needed nutrition of the subcutaneous tissue is also blocked, so that the part blocked firstly locally causes the hair follicle blockage (such as alopecia) and the muscle atrophy (such as the face-to-face aging).
And fourthly, the autonomic peristalsis osmotic pressure power of the organ nerve terminal micro blood vessels is reduced, the circulation of rich capillary micro blood vessels is blocked, the metabolism is difficult, the nutrition is difficult to supply, and the nutrition is insufficient. Especially local blockage or obstruction, inevitably leads to nervous atrophy of organs, resulting in functional disorders (e.g. sexual reproduction disorders).
Bioelectricity is an objective natural phenomenon and is communicated with the nature, and the conduction of bioelectricity is to extend the blood vessels and organs of transmitters through meridians and collaterals, excite the cells of vessels and tissues and form the positive electricity outside the cells and the negative electricity inside the cells. When the human body is in a flat static state, a potential difference of minus 70-90 millivolts exists between the inside and the outside of cells, the bioelectricity is flat, and the bioelectricity is increased when the human body is active or stimulated. The tidal effect of human microcirculation is the conduction of biological electrokinetic energy of meridians, when the bioelectric current is mild, the tidal effect of blood vessels is slow, when the bioelectric current is increased, the tidal effect of blood vessels is intensified, such as sea waves of different grades, to push the operation of the microcirculation blood vessels of human body.
Bioelectricity in human meridians and collaterals plays a leading role in the operation, transport and metabolism of human microcirculation. The kinetic energy of bioelectricity in channels and collaterals mainly depends on the action of ions such as carbonic acid, hydrogen chloride, potassium, sodium, calcium and the like, wherein the action of the hydrogen chloride is strongest, and the inorganic strong acid has strong electric property. Therefore, the application of the moderate hydrogen chloride component can not react with organic acid except for protecting organic substances and organic muscles, has strong electric conductivity, and is an ideal substance for promoting the natural electric conduction of channels and collaterals and the kinetic energy of the transmitter of the human body.
At present, no specific medicine or health-care product is available for internal conditioning of human body microcirculation meridian bioelectricity, and only external physical therapy physical electro-therapeutic instruments, pulse instruments and other instruments can play a role in transient assistance. But also only aims at the target disease treatment, temporary control and temporary relief of the human body, and does not achieve the fundamental conditioning effect on the deep layer of human microcirculation.
Disclosure of Invention
The invention aims to provide a moderate hydrogen chloride component for conditioning bioelectricity of human channels and collaterals and application thereof, and solves the problem of insufficient internal power function of bioelectricity of human microcirculation channels and collaterals through new application of a hydrogen chloride substance.
In order to achieve the above purpose, the invention provides the following technical scheme: the moderate hydrogen chloride component for conditioning bioelectricity of human channels and collaterals comprises the following raw materials: purified water, food-grade additive hydrogen chloride and food sodium chloride, wherein the content of the sodium chloride in the purified water is 0-3000 mg/100-: 0.9-6.9.
Preferably, the appropriate hydrogen chloride component has the following standards of pH, impurities, physical compounds, microorganisms and the like:
moderate PH:
the pH value of the concentrated acid solution is 0.9-2.9; the pH value of the diluted acid water is 3.0-6.9;
impurities (according to GB/T5749):
the chroma is less than or equal to 10 and no other heterochrosis exists; turbidity is less than or equal to 1;
odor and peculiar smell are avoided; visible matter, none;
physical (GB/T5750 compliant):
oxygen consumption, mg/L is less than or equal to 0.05 percent; nitrite, mg/L is less than or equal to 0.005 percent;
residual chlorine, mg/L is less than or equal to 0.05 percent; lead, mg/L is less than or equal to 0.01 percent;
cadmium, mg/L is less than or equal to 0.005 percent; mercury, mg/L is less than or equal to 0.003 percent;
arsenic, mg/L is less than or equal to 0.01 percent; copper, mg/L is less than or equal to 0.9 percent;
trichloromethane, mg/L is less than or equal to 0.02 percent; the mg/L of volatile phenol (calculated by phenol) is less than or equal to 0.002 percent;
total alpha radioactivity, Bq/L is less than or equal to 0.1 percent; total beta radioactivity, Bq/L is less than or equal to 0.9 percent;
microorganisms (conforming to GB/T4789):
the total number of colonies, cfu/mL, is less than or equal to 50 percent; coliform group, mpn/mL is less than or equal to 0.03%;
mould, cfu/mL is less than or equal to 9%; yeast, cfu/mL is less than or equal to 9%;
pathogenic bacteria (salmonella, shigella, and staphylococcus aureus) are absent.
Preferably, the moderate hydrogen chloride component has a carbohydrate, protein and fat content standard of:
0% of carbohydrate;
0% of protein;
fat 0%.
The preparation process of moderate hydrogen chloride component for regulating bioelectricity of human body channels and collaterals comprises the following specific operation steps:
the method comprises the following steps: preparing raw materials, obtaining purified water, food-grade additive hydrogen chloride and food sodium chloride, and purifying the raw materials by removing impurities, physical substances and microorganisms;
step two: dissolving food sodium chloride into purified water according to a required proportion to ensure that the content of the sodium chloride in the purified water is 0-3000 mg/100-: 0.9-2.9 (concentrated acid solution) and 3.0-6.9 (diluted acid solution);
step three: filtering with high adsorption nanometer material purifier to obtain clear liquid, heating the mixed liquid to 15-50 deg.C, stirring for 2-3min, and standing for 30-50min to obtain appropriate hydrogen chloride component.
Preferably, the device for the moderate hydrogen chloride component in the third step is provided with a pressurization of 1-3 standard atmospheric pressure.
The moderate hydrogen chloride component for regulating the bioelectricity of human body channels and collaterals and the application thereof are used for improving the power effect of the transmission transmitter of the bioelectricity of the channels and collaterals, promoting the function of physiological microcirculation self-discipline peristaltic osmotic pressure perfusion and improving the smoothness and the transportability of the microcirculation of blood vessels.
Preferably, the moderate hydrogen chloride component is used for promoting microcirculation of a digestive system, and the moderate hydrogen chloride component is used for preparing a conditioning medicine for beautifying, building bodies and improving obesity and emaciation.
Preferably, the moderate hydrogen chloride component is used for promoting microcirculation of subcutaneous tissues, and the moderate hydrogen chloride component is used for preparing conditioning medicines for promoting hair growth, protecting hair, beautifying and improving alopecia and aging of face.
Preferably, the moderate hydrogen chloride component is used for promoting microcirculation of nerve terminals, and the moderate hydrogen chloride component is used for preparing a conditioning medicine for sexual reproduction health care and sexual functional reproduction disorder improvement.
In the technical scheme, the invention provides the following technical effects and advantages:
by taking the moderate hydrogen chloride component, the action of the hydrogen chloride substance on the conduction transmitter of bioelectricity of human channels and collaterals is increased, and the effect of the microcirculation self-discipline peristaltic osmosis osmotic pressure tidal force perfusion wave of the human body is strengthened, so that the deep regulation of the microcirculation of subcutaneous tissues and organs is achieved, the smoothness and the transportability of the microcirculation of the human body are maintained and improved, the metabolism of the human body is ensured, the obesity, the emaciation, the alopecia, the aging of the face and the sexual function reproductive disorder and the like of the human body are naturally and effectively controlled and solved, and the young posture and the physiological activity of the human body are effectively maintained.
The supplement shows that the hydrogen chloride reacts with trace metal substances of the human body to generate chloride, and the chloride is the best nutrient needed by the human body. Therefore, the human body intakes the moderate hydrogen chloride component, which not only enhances the human body microcirculation system improved by the bioelectricity kinetic energy of the human body channels and collaterals, but also increases the sublimed nutrient and better maintains the life health state of the human body.
Detailed description of the invention
The present invention will be described in further detail below in order to enable those skilled in the art to better understand the technical solution of the present invention.
The invention provides a moderate hydrogen chloride component for conditioning bioelectricity of human channels and collaterals, which comprises the following raw materials: purified water, food-grade additive hydrogen chloride and food sodium chloride.
The content of the sodium chloride in the purified water is 0-3000 mg/100-: 0.9-6.9.
The standards of the moderate hydrogen chloride component such as PH value, impurities, physical substances, microorganisms and the like are as follows:
moderate PH:
the pH value of the concentrated acid solution is 0.9-2.9; the pH value of the diluted acid water is 3.0-6.9;
impurities (according to GB/T5749):
the chroma is less than or equal to 10 and no other heterochrosis exists; turbidity is less than or equal to 1;
odor and peculiar smell are avoided; visible matter, none;
physical (GB/T5750 compliant):
oxygen consumption, mg/L is less than or equal to 0.05 percent; nitrite, mg/L is less than or equal to 0.005 percent;
residual chlorine, mg/L is less than or equal to 0.05 percent; lead, mg/L is less than or equal to 0.01 percent;
cadmium, mg/L is less than or equal to 0.005 percent; mercury, mg/L is less than or equal to 0.003 percent;
arsenic, mg/L is less than or equal to 0.01 percent; copper, mg/L is less than or equal to 0.9 percent;
trichloromethane, mg/L is less than or equal to 0.02 percent; the mg/L of volatile phenol (calculated by phenol) is less than or equal to 0.002 percent;
total alpha radioactivity, Bq/L is less than or equal to 0.1 percent; total beta radioactivity, Bq/L is less than or equal to 0.9 percent;
microorganisms (conforming to GB/T4789):
the total number of colonies, cfu/mL, is less than or equal to 50 percent; coliform group, mpn/mL is less than or equal to 0.03%;
mould, cfu/mL is less than or equal to 9%; yeast, cfu/mL is less than or equal to 9%;
pathogenic bacteria (salmonella, shigella, and staphylococcus aureus) are absent.
The content standards of carbohydrate, protein, fat and the like in the moderate hydrogen chloride component are as follows:
0% of carbohydrate;
0% of protein;
fat 0%.
The preparation process of the moderate hydrogen chloride component for conditioning bioelectricity of human channels and collaterals comprises the following operation steps:
the method comprises the following steps: preparing raw materials, obtaining purified water, food-grade additive hydrogen chloride and food sodium chloride, and purifying the raw materials by removing impurities, physical substances and microorganisms;
step two: dissolving food sodium chloride into purified water according to a required proportion to ensure that the content of the sodium chloride in the purified water is 0-3000 mg/100-: 0.9-2.9 (concentrated acid solution) and 3.0-6.9 (diluted acid solution);
step three: filtering with high adsorption nanometer material purifier to obtain clear liquid, heating the mixed liquid to 15-50 deg.C, stirring for 2-3min, and standing for 30-50min to obtain appropriate hydrogen chloride component.
And setting the pressurizing pressure in the device for moderate hydrogen chloride component in the third step to be 1-3 standard atmospheric pressure.
The moderate hydrogen chloride component for regulating the bioelectricity of human body channels and collaterals and the application thereof are used for improving the conduction transmitter kinetic energy of the bioelectricity of the channels and collaterals, promoting the function of physiological microcirculation self-discipline peristaltic osmotic pressure perfusion, and improving the smoothness and the transportability of the microcirculation of blood vessels.
The moderate hydrogen chloride component is used for promoting the microcirculation of the digestive system, and the moderate hydrogen chloride component is used for preparing the conditioning medicine for beautifying the body, building the body and improving the adiposity and the emaciation.
The moderate hydrogen chloride component prepared in the embodiment has high purity and no obvious impurities, achieves the taking index of the moderate hydrogen chloride component which is completely nontoxic, harmless, safe and free of any side effect, has obvious regulation effect when being applied to the regulation and treatment of obesity and emaciation, mainly embodies the functions of enhancing the conduction transmitter kinetic energy of bioelectricity of a human body, promoting the elasticity, toughness and permeability of microcirculation and blood vessels, promoting the expansion and contraction power of the blood vessels, enhancing the absorption, consumption and discharge functions of organism tissue cells, and achieves the purposes of strengthening the body and building the body.
Example 1:
the feasibility of the moderate hydrogen chloride component produced in the embodiment is verified in corresponding experience tests, 5 weight-losing volunteers with different heights and 5 health-improving volunteers with different heights are respectively found in a weight range of 80-100kg and a weight range of 40-60kg in a 30-40-year-old population, the weight of the weight-losing volunteers is obviously reduced after three months and the weight of the health-improving volunteers is obviously improved under the condition that the diet and exercise habits are converged by normally drinking the moderate hydrogen chloride component as required, the moderate pH value is 3.5 +/-0.3 diluted acid water, 1500 ml/day (three times in the morning, evening), and the appetite and appetite of the weight-reducing volunteers are obviously improved no matter the weight-losing volunteers or the health-improving volunteers, so that the physical function is improved.
Example 2:
the feasibility of the moderate hydrogen chloride component produced in the embodiment is verified in corresponding experience tests, 5 weight-losing volunteers with different heights and 5 health-improving volunteers with different heights are respectively found in a weight range of 80-100kg and a weight range of 40-60kg in a 40-50-year-old population, the weight of the weight-losing volunteers is obviously reduced after three months and the weight of the health-improving volunteers is obviously improved under the condition that the diet and exercise habits are converged and the moderate hydrogen chloride component is normally drunk as required, the moderate pH value is 3.5 +/-0.3 diluted acid water and 1500 ml/day (three times in the morning, evening), and the appetite and appetite of the weight-reducing volunteers are obviously improved and the physical function of the weight-reducing volunteers and the health-improving volunteers are improved.
Example 3:
the feasibility of the moderate hydrogen chloride component produced in the embodiment is verified in corresponding experience tests, 5 weight-losing volunteers with different heights and 5 strengthening volunteers with different heights are respectively found in a weight range of 80-100kg and a weight range of 40-60kg in a population of 50-60 years old, the weight of the weight-losing volunteers is obviously reduced after three months and the weight of the strengthening volunteers is obviously improved under the condition that the diet and exercise habits are converged by normally drinking the moderate acid water with the moderate pH value of 3.5 +/-0.3 of the moderate hydrogen chloride component according to requirements and 1500 ml/day (three times in the morning, evening), and the appetite and appetite of the weight-losing volunteers are obviously improved and the physical function of the weight-losing volunteers or the strengthening volunteers are improved.
The following table is obtained according to examples 1 to 3:
as can be seen from the above table, the moderate hydrogen chloride compositions prepared in the tables of examples 1 to 3 have significant effects on the adjustment and treatment of obesity and emaciation at different ages, so that the application of the moderate hydrogen chloride compositions is suitable for popularization.
Similarly, the moderate hydrogen chloride component is used for promoting the microcirculation of subcutaneous tissues, and the moderate hydrogen chloride component is used for preparing conditioning medicines for growing hair, protecting hair, maintaining beauty, improving alopecia and aging face, and has good effect in the embodiment. And will not be described in detail herein.
Similarly, the moderate hydrogen chloride component is used for promoting the microcirculation of the nerve terminals, and the moderate hydrogen chloride component is used for preparing a conditioning medicine for improving sexual dysfunction in sexual reproduction health care, and has good effect in the embodiment. And will not be described in detail herein.
Value of the invention
It is well known that in medical "physiology" textbooks it is clear that: the hydrogen chloride can activate pepsinogen in the stomach to make it become pepsin to play a role; the hydrogen chloride also provides a PH environment required by the activity of the pepsin, promotes the denaturation of protein in food, facilitates the digestion of the protein, and has the functions of bacteriostasis and sterilization; the hydrogen chloride can promote secretional of secretional liquid of pancreas, cause the acid environment of duodenum, promote the absorption of iron and calcium of small intestine.
Therefore, the human body supplements a proper hydrogen chloride component, helps to supplement the deficiency of the intrinsic gastric acid to secrete hydrogen chloride, promotes the conduction transmitter kinetic energy of human body channel bioelectricity, promotes the automatic peristaltic osmotic pressure of human body microcirculation blood vessels such as tidal wave type perfusion exercise, strengthens the smoothness and the transportability of the microcirculation blood vessels, effectively changes the intrinsic physiological circulation system of the human body, regulates the acidification of the human body caused by the poor microcirculation, recovers the health state of the human body, enables the obese to lose weight and be healthy, enables the slimming and body building to strengthen, enables the hair loss to grow and protect, enables the face to be aged, beautifies and enables the impaired sexual function and reproductive function to be recovered.
In a word, the proper hydrogen chloride component can keep the long-acting activity balance of human body functions, maintain and improve the conduction kinetic energy of human microcirculation, and fundamentally improve the human microcirculation system to achieve deep conditioning of physique. Moreover, solid-state resistance substances generated by human body congestion, such as calcified substances, atherosclerotic plaques, stones, thrombus, fat and other solid-state wastes formed by flocculation and precipitation in blood vessels of a human body, are eliminated by taking a proper amount of hydrogen chloride components, and the solid-state substances are dissolved and separated and converted into a water-soluble liquid state, so that the resistance phenomenon of bioelectricity of meridians and collaterals of the human body is reduced, the bioelectricity of meridians and collaterals reaches each part and each cell of the human body in a transmission transmitter, and the metabolism of the human body is guaranteed. Meanwhile, the chloride is generated by reacting with metal substances, and the chloride is the best nutrient needed by human body, such as: calcium chloride is the best choice for supplementing calcium for human body (calcium chloride which can be dissolved in water is uniformly used for treating calcium-deficient patients in hospitals), and potassium chloride, magnesium chloride, sodium chloride and the like are all indispensable nutrients for human body. The immunity of the human body can be better improved, and the young physical state and the physiological activity of the human body can be effectively kept.
The moderate hydrogen chloride component of the invention is the application of hydrogen chloride substances in the new field of bioelectricity for regulating human channels and collaterals. Therefore, the invention is developed, aiming at the particularity of bioelectricity conduction transmitters of human body channels and collaterals, the invention adopts high-adsorption nano materials and a novel process to adsorb and filter the food-grade hydrogen chloride, so as to achieve the administration index of the proper hydrogen chloride component which is completely safe, has no side effect and can be effectively conditioned, and the administration index is higher than the national drinking water quality standard, and the proper hydrogen chloride component can reach the transfusion standard after the purification technology is updated.
While certain exemplary embodiments of the present invention have been described above by way of illustration only, it will be apparent to those of ordinary skill in the art that the described embodiments may be modified in various different ways without departing from the spirit and scope of the invention. Therefore, the above description is illustrative in nature and should not be construed as limiting the scope of the invention, which is defined by the appended claims, and any modifications, equivalents, improvements and the like, which come within the spirit and scope of the invention are intended to be embraced therein.
Claims (9)
1. The moderate hydrogen chloride component for conditioning bioelectricity of human channels and collaterals is characterized in that: the moderate hydrogen chloride component comprises the following raw materials: purified water, food grade additive hydrogen chloride and food sodium chloride;
the content of the sodium chloride in the purified water is 0-3000 mg/100-: 0.9-2.9 (concentrated acid solution) and 3.0-6.9 (diluted acid solution).
2. A moderate hydrogen chloride composition for conditioning bioelectricity in the human meridians according to claim 1, wherein: the standards of the moderate hydrogen chloride component such as PH value, impurities, physical substances, microorganisms and the like are as follows:
moderate PH:
the pH value of the concentrated acid solution is 0.9-2.9; the pH value of the diluted acid water is 3.0-6.9;
impurities (according to GB/T5749):
the chroma is less than or equal to 10 and no other heterochrosis exists; turbidity is less than or equal to 1;
odor and peculiar smell are avoided; visible matter, none;
physical (GB/T5750 compliant):
oxygen consumption, mg/L is less than or equal to 0.05 percent; nitrite, mg/L is less than or equal to 0.005 percent;
residual chlorine, mg/L is less than or equal to 0.05 percent; lead, mg/L is less than or equal to 0.01 percent;
cadmium, mg/L is less than or equal to 0.005 percent; mercury, mg/L is less than or equal to 0.003 percent;
arsenic, mg/L is less than or equal to 0.01 percent; copper, mg/L is less than or equal to 0.9 percent;
trichloromethane, mg/L is less than or equal to 0.02 percent; the mg/L of volatile phenol (calculated by phenol) is less than or equal to 0.002 percent;
total alpha radioactivity, Bq/L is less than or equal to 0.1 percent; total beta radioactivity, Bq/L is less than or equal to 0.9 percent;
microorganisms (conforming to GB/T4789):
the total number of colonies, cfu/mL, is less than or equal to 50 percent; coliform bacteria, mpn/100mL is less than or equal to 3%;
mould, cfu/mL is less than or equal to 9%; yeast, cfu/mL is less than or equal to 9%;
pathogenic bacteria (salmonella, shigella, and staphylococcus aureus) are absent.
3. A moderate hydrogen chloride composition for conditioning bioelectricity in the human meridians according to claim 1, wherein: the content standards of carbohydrate, protein, fat and the like in the moderate hydrogen chloride component are as follows:
0% of carbohydrate;
0% of protein;
fat 0%.
4. A process for preparing a moderate hydrogen chloride component for regulating bioelectricity of human meridians according to any one of claims 1 to 3, which comprises: the operation steps are as follows:
the method comprises the following steps: preparing raw materials, obtaining purified water, food-grade additive hydrogen chloride and food sodium chloride, and purifying the raw materials by removing impurities, physical substances and microorganisms;
step two: dissolving food sodium chloride into purified water according to a required proportion to ensure that the content of the sodium chloride in the purified water is 0-3000 mg/100-: 0.9-2.9 (concentrated acid solution) and 3.0-6.9 (diluted acid solution);
step three: filtering with high adsorption nanometer material purifier to obtain clear liquid, heating the mixed liquid to 15-50 deg.C, stirring for 2-3min, and standing for 30-50min to obtain appropriate hydrogen chloride component.
5. The process for preparing moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals as claimed in claim 4, wherein: and setting the pressurizing pressure in the device for moderate hydrogen chloride component in the third step to be 1-3 standard atmospheric pressure.
6. The application of moderate hydrogen chloride component for conditioning bioelectricity of human channels and collaterals is characterized in that: the moderate hydrogen chloride component is used for improving the dynamic effect of the biological electric conduction transmitter of the channels and collaterals, promoting the function of physiological microcirculation self-discipline peristaltic osmosis osmotic pressure perfusion and improving the smoothness and the transportability of microcirculation and microcirculation blood vessels.
7. The use of a moderate hydrogen chloride composition for conditioning bioelectricity in the human meridians according to claim 6, wherein: the moderate hydrogen chloride component is used for promoting the microcirculation of the digestive system, and the moderate hydrogen chloride component is used for preparing the conditioning medicine for beautifying the body, building the body and improving the adiposity and the emaciation.
8. The use of a moderate hydrogen chloride composition for conditioning bioelectricity in the human meridians according to claim 6, wherein: the moderate hydrogen chloride component is used for promoting microcirculation of subcutaneous tissues, and the moderate hydrogen chloride component is used for preparing conditioning medicines for growing hair, protecting hair, maintaining beauty, improving alopecia and aging face.
9. The use of a moderate hydrogen chloride composition for conditioning bioelectricity in the human meridians according to claim 6, wherein: the moderate hydrogen chloride component is used for promoting microcirculation of nerve terminals, and the moderate hydrogen chloride component is used for preparing a conditioning medicine for improving sexual reproduction disorder by sexual reproduction health care.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210486485.4A CN114984040A (en) | 2021-04-28 | 2021-04-28 | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof |
| CN202110470601.9A CN113181209A (en) | 2021-04-28 | 2021-04-28 | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110470601.9A CN113181209A (en) | 2021-04-28 | 2021-04-28 | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210486485.4A Division CN114984040A (en) | 2021-04-28 | 2021-04-28 | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113181209A true CN113181209A (en) | 2021-07-30 |
Family
ID=76980460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210486485.4A Pending CN114984040A (en) | 2021-04-28 | 2021-04-28 | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof |
| CN202110470601.9A Pending CN113181209A (en) | 2021-04-28 | 2021-04-28 | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210486485.4A Pending CN114984040A (en) | 2021-04-28 | 2021-04-28 | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN114984040A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1030834B1 (en) * | 2024-01-13 | 2025-01-07 | Yongmao Huang | A Dietary Method to Regulate Meridian Bioelectricity with Hydrogen Chloride Compound Solution for Diabetes and Hyperlipidemia |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05262709A (en) * | 1991-06-28 | 1993-10-12 | Fujisawa Pharmaceut Co Ltd | Propionamide derivative |
| CN103463337A (en) * | 2013-08-22 | 2013-12-25 | 邢波 | Traditional Chinese medicine for treating axillary acute purulent lymphadenitis caused by blockage of channels and collaterals |
| CN104244959A (en) * | 2011-12-04 | 2014-12-24 | 大卫·L·刘 | Pharmaceutical composition of sodium ion and calcium ion and method for treating cancer, tumor and non-malignant proliferative disease |
-
2021
- 2021-04-28 CN CN202210486485.4A patent/CN114984040A/en active Pending
- 2021-04-28 CN CN202110470601.9A patent/CN113181209A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05262709A (en) * | 1991-06-28 | 1993-10-12 | Fujisawa Pharmaceut Co Ltd | Propionamide derivative |
| CN104244959A (en) * | 2011-12-04 | 2014-12-24 | 大卫·L·刘 | Pharmaceutical composition of sodium ion and calcium ion and method for treating cancer, tumor and non-malignant proliferative disease |
| CN103463337A (en) * | 2013-08-22 | 2013-12-25 | 邢波 | Traditional Chinese medicine for treating axillary acute purulent lymphadenitis caused by blockage of channels and collaterals |
Non-Patent Citations (2)
| Title |
|---|
| 哈尔滨药学会: "《制剂手册》", 31 October 1980, 哈尔滨市卫生局药政处 * |
| 柯铭清等: "《医院制剂》", 30 September 1980, 湖南科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1030834B1 (en) * | 2024-01-13 | 2025-01-07 | Yongmao Huang | A Dietary Method to Regulate Meridian Bioelectricity with Hydrogen Chloride Compound Solution for Diabetes and Hyperlipidemia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114984040A (en) | 2022-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101574166B (en) | Ocean deep water-containing drinking water with health care function | |
| CN104304577A (en) | Biological beverage with camellia chrysantha as carrier and preparation method thereof | |
| ES2357293T3 (en) | METHOD OF PREPARATION OF CALCIUM GLUCONATE. | |
| KR20110013685A (en) | Functional beverage composition containing marine deep water, fermented black ginger extract and jujube concentrate | |
| CN113181209A (en) | Moderate hydrogen chloride component for regulating bioelectricity of human channels and collaterals and application thereof | |
| WO2021120486A1 (en) | Lithium ion composition and application thereof | |
| LU503427B1 (en) | Application of Moderate Hydrogen Chloride Component for Enhancing Biological Electrical Wave Energy of Human Meridians in Dietary Therapy for Hypertension and Hypotension | |
| KR20100074885A (en) | Method for manufacturing alkali calcium cleaning salts | |
| CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
| CN110584099A (en) | Highland barley green juice powder and preparation method thereof | |
| WO2005004639A1 (en) | Process for producing liquid formulation containing raw yeast and liquid formulation | |
| KR101772403B1 (en) | Mineral water manufacturing method | |
| CN113476572A (en) | Dendrobium nobile cream and preparation method thereof | |
| CN2652920Y (en) | Ion oxygen enriched water producing device | |
| CN1362374A (en) | Multiple-element mineralized drinking water | |
| KR20100117168A (en) | A functional beverage comprising deep sea water, collagen, extract of japanese apricot and polydextrose as main ingredients | |
| CN101215505A (en) | Complete nutrition wine capable of restoring gene and activating prostate cell and preparation method thereof | |
| CN107183430A (en) | A kind of chrysanthemum beverage whetted the appetite and preparation method thereof | |
| CN114209713A (en) | Method for promoting human body leucocyte growth and cleaning bad cells | |
| CN102764269B (en) | Nasal cavity health care cleansing solution and preparation method thereof | |
| CN106277272A (en) | A kind of multi-functional drinking water and production method thereof and application | |
| CN100478286C (en) | Prepn of health floated lake salt solution | |
| CN113180169A (en) | Beverage mother liquor and preparation method and application thereof | |
| CN1533716A (en) | Beverage containing fresh jinger juice | |
| CN1096647A (en) | Nutrient element extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |